Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection

WHO, 2017 Goletti, 2014, Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches, J Rheumatol Suppl, 91, 24, 10.3899/jrheum.140099 Lalvani, 2010, A 100 year update on diagnosis of tuberculosis infection, Br Med Bull, 93, 69, 10.1093/bmb/ldp039 Arend, 2007, Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts, Am J Respir Crit Care Med, 175, 618, 10.1164/rccm.200608-1099OC Menzies, 2007, Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research, Ann Intern Med, 146, 340, 10.7326/0003-4819-146-5-200703060-00006 Petruccioli, 2016, Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis, Eur Respir J, 48, 1751, 10.1183/13993003.01012-2016 Petruccioli, 2017, Analytical evaluation of QuantiFERON- plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis, Tuberculosis (Edinb), 106, 38, 10.1016/j.tube.2017.06.002 Barcellini, 2016, First independent evaluation of QuantiFERON-TB Plus performance, Eur Respir J, 47, 1587, 10.1183/13993003.02033-2015 Boom, 2003, Human immunity to M. tuberculosis: T cell subsets and antigen processing, Tuberculosis (Edinb), 83, 98, 10.1016/S1472-9792(02)00054-9 Busch, 2016, Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis, Am J Respir Crit Care Med, 194, 345, 10.1164/rccm.201509-1746OC Brookes, 2003, CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages, Eur J Immunol, 33, 3293, 10.1002/eji.200324109 Turner, 1996, Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro, Immunology, 87, 339, 10.1046/j.1365-2567.1996.512590.x Chiacchio, 2014, Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients, J Infect, 69, 533, 10.1016/j.jinf.2014.06.009 Nikolova, 2013, Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection, Diagn Microbiol Infect Dis, 75, 277, 10.1016/j.diagmicrobio.2012.11.023 Rozot, 2015, Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis, Clin Infect Dis, 60, 432, 10.1093/cid/ciu795 Rozot, 2013, Mycobacterium tuberculosis-specific CD8 T cells are functionally and phenotypically different between latent infection and active disease, Eur J Immunol, 43, 1568, 10.1002/eji.201243262 Petruccioli, 2016, First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus, J Infect, 73, 588, 10.1016/j.jinf.2016.09.008 Goletti, 2018, Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease, Respirology, 23, 455, 10.1111/resp.13272 Telisinghe, 2017, The sensitivity of the QuantiFERON(®)-TB Gold Plus assay in Zambian adults with active tuberculosis, Int J Tubercul Lung Dis, 21, 690, 10.5588/ijtld.16.0764 Ruhwald, 2011, A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis, Tuberculosis (Edinb), 91, 260, 10.1016/j.tube.2011.01.001 Ruhwald, 2008, Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis, Eur Respir J, 32, 1607, 10.1183/09031936.00055508 Ruhwald, 2008, Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10, PLoS One, 3, e2858, 10.1371/journal.pone.0002858 Ruhwald, 2012, IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions, Expert Rev Mol Diagn, 12, 175, 10.1586/erm.11.97 Goletti, 2010, IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis, J Infect, 61, 133, 10.1016/j.jinf.2010.05.002 Petrone, 2016, Blood and urine inducible protein 10 as potential markers of disease activity, Int J Tubercul Lung Dis, 20, 1554, 10.5588/ijtld.16.0342 Petrone, 2015, Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children, BioMed Res Int, 2015, 10.1155/2015/589471 Vanini, 2012, IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country, J Infect, 65, 49, 10.1016/j.jinf.2012.03.017 Yassin, 2013, Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection, Eur Respir J, 41, 644, 10.1183/09031936.00012212 Azzurri, 2005, IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection, Microb Infect, 7, 1, 10.1016/j.micinf.2004.09.004 Chegou, 2013, Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting, PLoS One, 8, 10.1371/journal.pone.0064226 Petrucci, 2008, Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection, Pediatr Infect Dis J, 27, 1073, 10.1097/INF.0b013e31817d05a3 Kabeer, 2011, Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects, Diagn Microbiol Infect Dis, 71, 236, 10.1016/j.diagmicrobio.2011.07.012 Cannas, 2010, IP-10 detection in urine is associated with lung diseases, BMC Infect Dis, 10.1186/1471-2334-10-333 Day, 2011, Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load, J Immunol, 187, 2222, 10.4049/jimmunol.1101122 Petrone, 2014, High urine IP-10 levels associate with chronic HCV infection, J Infect, 68, 591, 10.1016/j.jinf.2014.02.008 Aabye, 2010, Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients, Eur Respir J, 36, 1488, 10.1183/09031936.00039010 Chen, 2011, Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis, Int J Tubercul Lung Dis, 15, 192 Villar-Hernandez, 2017, Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases, J Infect, 75, 315, 10.1016/j.jinf.2017.07.004 Aabye, 2012, A simple method to quantitate IP-10 in dried blood and plasma spots, PLoS One, 7, 10.1371/journal.pone.0039228 Aabye, 2013, Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper, Eur Respir J, 42, 495, 10.1183/09031936.00129412 Ruhwald, 2012, IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection, PLoS One, 7, 10.1371/journal.pone.0045181